On World Tuberculosis Day, various organizations and researchers are highlighting efforts to combat tuberculosis. Bharat Biotech has initiated clinical trials of a TB vaccine in India, the first derived from a human source by a Spanish company. WHO emphasizes the importance of consistent antibiotic treatment for TB. Studies show new inhibitors and gene mutations associated with TB treatment. Recommendations include rapid molecular TB tests for early diagnosis. Efforts are ongoing to prevent TB through community engagement and infection control.
#BharatBiotech starts clinical trials of #TB jab https://t.co/QFIAHU2D3E
Thank you Trevor for the highlight! #EndTB https://t.co/vEYbF03JtI
What is the long-term effectiveness of #tuberculosis preventive therapy? https://t.co/iH1QdKG3qs #idtwitter https://t.co/c2tjeNrbaq
NEW Position Paper—Classification of early #tuberculosis states to guide research for improved care and prevention From Anna Coussens and colleagues https://t.co/xAKRI1aYFW #WorldTBDay #EndTB #YesWeCanEndTB https://t.co/7iVxvup3K1
Latent TB infection can hide in your body without symptoms, and without being contagious. Prevent it from becoming active with the right testing and treatment. Think you're at risk? See your healthcare provider. Learn more: https://t.co/4HZLNlFMVN. #WorldTBDay #StopTBDC https://t.co/m6jahy7N71
TB can be prevented by 👉engaging communities to screen at-risk populations 👉providing preventive treatment for those who need it 👉 following good infection control https://t.co/q8wfhyrrlK https://t.co/Ktd3nZi9Cr
Achieving universal social protection for people with tuberculosis #TB https://t.co/T3p1wGPO9v
On 2024 #WorldTBDay, we highlight the recent study "T cell receptor repertoires associated with control and disease progression following Mycobacterium #tuberculosis infection" Read it here 👉🏽 https://t.co/qI0i31sT9e
On March 19, 2024, the Bill & Melinda Gates Medical Research Institute announced the start of a phase 3 trial of its tuberculosis vaccine candidate M72/AS01E. Find out more in a World Report from Talha Burki: https://t.co/6B3VKkUkb9 #WorldTBDay https://t.co/jDQC6n7lnx
Multidrug-resistant #tuberculosis (TB) is a form of TB caused by bacteria that do not respond to the 2 most effective first-line TB drugs. Multidrug-resistant TB is treatable and curable by using WHO-recommended all-oral treatment 👉https://t.co/NQ5A5GuMrA #EndTB #WorldTBDay https://t.co/j1cWaEk9Zq
On #WorldTBDay, we highlight the recent study "Comparison of two diagnostic intervention packages for community-based active case finding for #tuberculosis: an open-label randomized controlled trial" Read it here 👉 https://t.co/XDU7bgMQGd
Bharat Biotech International Ltd says, it started clinical trials of the Tuberculosis vaccine #MTBVAC on adults in India. This is the first vaccine against #Tuberculosis derived from a human source by the Spanish bio pharmaceutical company, #Biofabri. The trials are carried… https://t.co/fqPylJzP64
An analysis last year in Science of more than 51,000 clinical isolates of the bacterium responsible for #tuberculosis found previously unknown gene mutations associated with enhanced survival of the bacteria following antibiotic treatment. https://t.co/nEr6oB3WDn #WorldTBDay https://t.co/fXFPYiuA4f
Bharat Biotech Begins Clinical Trials Of TB Vaccine On Adults In India https://t.co/22rSF7HWgg https://t.co/IDLjdrNHSr
To ensure quick diagnosis and early treatment, WHO recommends the use of rapid molecular #tuberculosis (TB) tests as the initial diagnostic test for all persons with signs and symptoms of TB. 👉https://t.co/0jbErIdeIy #WorldTBDay #EndTB https://t.co/VgCEVVDOo2
#WATCH | Delhi: On World TB Day, Dr Urvashi B Singh, Professor, Incharge, Tuberculosis Division, Department of Microbiology, AIIMS says, " ...Tuberculosis is an airborne disease...the systems of TB are very normal, it is often misinterpreted as viral, if you have a mild fever in… https://t.co/XU033RsGNk
Clinical trials of Spanish tuberculosis vaccine MTBVAC begin in India, N. Ravi Kumar reports https://t.co/6bPRVtBa2F
Bharat Biotech begins clinical trials of TB vaccine on adults in India This is the first vaccine against Tuberculosis derived from a human source by the Spanish biopharmaceutical company, Biofabri, a press release from Bharat Biotech said. https://t.co/h154FOQRA7
A new inhibitor of Mycobacterium tuberculosis leucyl-tRNA synthetase is associated with bactericidal activity in humans and may be a candidate for combination therapy of #Tuberculosis #WorldTBDay https://t.co/QEWtSTHyHm
#WorldTBday The #tuberculosis epidemic in South Africa We speak with Prof. @ValerieMizrahi about the #TB burden in #SouthAfrica, challenges faced by researchers, & innovations to better understand the response required to accelerate progress #EndTB https://t.co/VHXFbo2spc
Yes! #Tuberculosis is curable! Tuberculosis is treated with antibiotics. To be effective, these medications need to be taken daily for 4–6 months. ⚠️ Stopping treatment early can lead to drug-resistant tuberculosis. Learn more 👉https://t.co/0jbErIdeIy #WorldTBDay #EndTB